Whole exome sequencing to unravel the genetics of neuralgic amyotrophy

Whole exome sequencing to unravel the genetics of neuralgic amyotrophy - Genetics of neuralgic amyotrophy

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON41857

Enrollment

250

Registered

2015-11-11

Start date

2016-05-28

Completion date

Unknown

Last updated

2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neuralgic amyotrophy / Brachial plexus neuritis

Interventions

Diagnosis

Genetics

Hereditary

Neuralgic amyotrophy

Eligibility

Age

18 Years to 64 Years

Inclusion criteria

Inclusion criteria: - NA patients known in the RUN Medical Centre - (Un)affected relatives of patients with NA in whom a de novo mutation has been identified - Informed consent

Exclusion criteria

Exclusion criteria: - Patients under the age of 18 years - Incompetent patients

Design outcomes

Primary

Measure	Time frame
The presence or absence of above described genetic changes in the study population.	—

Countries

The Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)